CA1105402A - Isolation of undegraded rna - Google Patents
Isolation of undegraded rnaInfo
- Publication number
- CA1105402A CA1105402A CA303,930A CA303930A CA1105402A CA 1105402 A CA1105402 A CA 1105402A CA 303930 A CA303930 A CA 303930A CA 1105402 A CA1105402 A CA 1105402A
- Authority
- CA
- Canada
- Prior art keywords
- rnase
- agent
- rna
- disulfide bond
- mercaptoethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000002955 isolation Methods 0.000 title abstract description 10
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims abstract description 11
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 claims abstract description 7
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims abstract description 5
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims abstract description 5
- 102000006382 Ribonucleases Human genes 0.000 claims abstract 2
- 108010083644 Ribonucleases Proteins 0.000 claims abstract 2
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 230000003196 chaotropic effect Effects 0.000 claims description 12
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical group SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 150000001450 anions Chemical class 0.000 claims description 6
- 150000001768 cations Chemical class 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 3
- 241000525154 Micrathena beta Species 0.000 claims 1
- 239000003161 ribonuclease inhibitor Substances 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 abstract description 16
- 238000002360 preparation method Methods 0.000 abstract description 5
- 230000002779 inactivation Effects 0.000 abstract description 3
- 230000002427 irreversible effect Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
- 238000004925 denaturation Methods 0.000 description 10
- 230000036425 denaturation Effects 0.000 description 10
- 210000000496 pancreas Anatomy 0.000 description 10
- 239000003398 denaturant Substances 0.000 description 9
- 241000700159 Rattus Species 0.000 description 8
- -1 guanylguanidinium Chemical compound 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 6
- 230000003389 potentiating effect Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 210000004153 islets of langerhan Anatomy 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- MJJFTDMZSMPNCL-UHFFFAOYSA-M lithium;2-hydroxy-3,4-diiodobenzoate Chemical compound [Li+].OC1=C(I)C(I)=CC=C1C([O-])=O MJJFTDMZSMPNCL-UHFFFAOYSA-M 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000004153 renaturation Methods 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- DYIFXNDAYPEXGI-UHFFFAOYSA-N 2-hydroxy-3,4-diiodobenzoic acid Chemical compound OC(=O)C1=CC=C(I)C(I)=C1O DYIFXNDAYPEXGI-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241000713838 Avian myeloblastosis virus Species 0.000 description 1
- 241000208199 Buxus sempervirens Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 241000518994 Conta Species 0.000 description 1
- VVNCNSJFMMFHPL-VKHMYHEASA-N D-penicillamine Chemical group CC(C)(S)[C@@H](N)C(O)=O VVNCNSJFMMFHPL-VKHMYHEASA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- SQSPRWMERUQXNE-UHFFFAOYSA-N Guanylurea Chemical compound NC(=N)NC(N)=O SQSPRWMERUQXNE-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 108010067035 Pancrelipase Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108010076181 Proinsulin Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000005549 deoxyribonucleoside Substances 0.000 description 1
- 229940075911 depen Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
RNAse is effectively inhibited during isolation of messenger RNA (mRNA) from cells or tissues by homogenizing a cell preparation in guanadinium thiocyanate buffered to low pH and containing mercaptoethanol. The combination of the added chemicals renders the inactivation of RNase essentially irreversible, allowing the mRNA to be isolated intact.
RNAse is effectively inhibited during isolation of messenger RNA (mRNA) from cells or tissues by homogenizing a cell preparation in guanadinium thiocyanate buffered to low pH and containing mercaptoethanol. The combination of the added chemicals renders the inactivation of RNase essentially irreversible, allowing the mRNA to be isolated intact.
Description
54~2 ll Isolation of intact messenger RNA (mRNA) from cells or tissues is !¦ technically extremely difficult due to the presence of the enzyme ribo-I' nuclease (RNase) which catalyzes ~he hydrolysis of a single phosphodiesterj bond in the ribonucleotide sequence. This en~yme is ubiquitous, axtremely ¦ stable and highly active. It is found on the skin, survives ordinary glassware washing techniqùes and sometimes con~aminates stocks of organic chemicals. The hydrolysis of a single phosphodiester bond within the mRN~
chain cannot be tolerated~ when the mRNA is isolated for cloning purposes, ,, since that would destroy the sequence continuity necessary to preserve ,i the genetic lnformation.
The difficul~ie~ are especially acute in dealing ~ith extracts of l! pancreas cells 7 since the pancreas is a source of digesti~e enzymes and ¦¦ therefore, is rich in RNase. HGwever, the problem of RNase contamination i is present in all tissues. The method disclosed herein to eliminate R~ase activity is applicable to all tissues. The exceptional effectiveness of the method is demonstrated in the present invention by the successful isolation of intact mRNA from isolated islet cells of the pancreas.
Prior Art RNase is a name applied collectively to a group of similar en~ymes 0 1 found to some extent in virtually all biological materials. Pancreatic RNase is a fairly typical example, and its structure is ~uite ~ell known.
The enzyme i5 a relatively low molecular weight protein possessing inter-molecular disulfide bonds. Catalytic activity is depen~ent upon a certain . . , . ~
a54q12 folded configuration of the amino acid chain, termed the native con-figuration. Denaturation is the name given to any process which leads to unfolding or rearrangement of the amino acid chain such that the nati~e, catalytically active configuration is lost.
Denaturation of RNase is relatively diff~cult to achieve. The inter--molecular disulfide bonds maintain the amino acid chain in a configuration approximating the native configuration. If the disulfide bonds are left intact, renaturation occurs rapidly, upon removal o~ denaturant. Even I when the disulfide bonds are broken, the enzyme is capable of spontaneously I recovering the native configuration under appropriate conditions, although li, the process is much slower.
¦¦ The denaturation of RNase by the use of chaotropic ions has been il reported. For a general discussion of chaotropes and denaturation, see I¦ Jencks, W.P., Catalysis in Chemistry and Enzymology, Chapt. 7 (1969). In ~I particular, the denaturation of RNase by guanidinium thlocyanate, a salt having both a chaotropic anion and a chaotropic cation, has been demon- !
strated by VonHippel, P.H. and Wong, K-Y, Science 145, 577 (1964).
Numerous strategies have been employed in the prior art to isolate j undegraded RNA from biological sources. The success of such procedures jj has been defined relative to the nature and purpose of the RNA isolation ¦l and to the amount of degradation which could be tolerated. One strategy employed in the prior art is the use of an adsorbant, such as bentonite, to remove RNase from the cell extract. Another strategy has been the ' complete deproteinization of the cell e~tract. Phenol i9 commonly used ii for this purpose. Guanidinium hydrochloride has also been employed as a li deproteinizing agent for the preparation of nucleic acids, and its use has been reviewed by Cox, R.A., Methods in Enzymology (L. Grossman and K. Moldave, eds.) vol. 12B, 120 (196~). Although such procedures may ¦I be employed to isolate high molecular weight RNA, they are not adequate !i for the isolation of mRNA for cloning purposes, where even the hydrolysis of a single phosphodiester bond would render the entire molecule useless ~ 354U2 for the purpose of transferring an intact gel~etic sequence to a micro-organism. The difficulties are exacerbated when the isolation is attempted from a tissue high in RNase content, such as pancreas. Rat pancreas contains as much as 200JUg of RNase per gram of tissue and even higher amounts are found to occur in other mammalian pancreases.
SUMMARY OF THE INVENTION
RNase is effectively inhibited during isolation ~rom intact cells by homogenizing a cell preparation in guanidinium thiocyanate buffered to low 1~ pH and containing mercaptoethanol. In combination with the denaturing , action of guanidinium thiocyanate, mercaptoethanol further reduces RNase Il acti~ity by disrupting its intermolecular disulfide bonds. The combination i of mercaptoethanol with a potent denaturing agent such as guanidinium 1, j thiocyanate, pursuant to this invention, tends to enhance the effectiveness Il of mercaptoethanol by rendering the inactivation of RNase essentially ,` irreversible. The pH may be varied in the range Df 5.0 - 8Ø
., , " DETAILED DESCRI~TION OF THE INVENTION -The present invention employs in combination a chaotropic anion, a chaotropic cation and a disulfide bond-breaking agent, during cell I disruption and during all operations required to separate RNA essentially ~I free from protein. The effectiveness of the combined action of the fore-going agents has been demonstrated by their use in the isolation of essentially undegraded mRNA in good yield from isolated islets of Langerhans of rat pancreas.
jl Choice of suitable chaotropic ions is based upon their solubility in li aqueous media and upon availability. Suitable chaotropic cations include li guanidinium, carbamoylguanidinium, guanylguanidinium, lithium and the like.
¦l Suitable chaotropic anions include iodide, perchlorate, thiocyanate, j diiodosalicylate and the like. The relatiYe effectiveness of salts formed 1l by combining such cations and anions will be determined in par~ by their l i , I ~, I! .
solubility. For example, lithium diiodosalicylate is a more potent denaturan~---than guanidinium thiocyanate, but it has a solubility of only about 0.lM and is also relatively expen-sive. Guanidinium thiocyanate provides the preferred cation-anion con~ination, because it is readily available and is highly soluble in aqueous media, up to about 5M.
Thiol compounds, such as ~-mercaptoethanol, are ~nown to break intramolecular disulfide bonds in proteins by a thiol-disulfide interchange reaction. Many suitable thiol compounds are known to be effective, including besides ~-mercaptoethanol, dithiothreitol, cysteine, propanol di-mercaptan and the like. Aqueous solubility is a necessary property, since the thiol compound must be present in large excess over the intramolecular disulfides, in order to drive the interchange reaction essentially to completion. ~-mercapto-ethanol is preferred because of its ready availability at reasonable price.
For the purpose of inhibiting RNase during extrac-tion of RNA from cells or tissues, the effectiveness of a given chaotropic salt is directly related to its concentra-tion. The preferred concentration is therefore the highest concentration that can be employed, as a practical matter.
The success of the present invention in preserving mRNA intact during extraction is thought to depend upon the rapidity with which the RNase is denatured, in addition to the extent of denaturation. This is thought to explain, for example, the superio~ity of guanidinium thiocyanate over the hydrochloride, despite the fact that the hydrochloride is only slightly less potent as a denaturing agent. The efectiveness of a denaturant is defined as the threshold concentration needed to achieve complete denaturation o a protein. On the other hand, the rate of denaturation of many proteins is ~ ~5~
dependent on the denaturant concentration, relative to the threshold, raised to from -the 5th to the 10th power. See Tanford, C.A., Ad~. Prot. Chem. 23, 121 (1968). Qualitatively this relationship suggests that a denaturant only slightly more potent than guanidinium hydrochloride can denature a protein many times more rapidly a~ the same concentration.
The relationship between the kinetics of RNase , 54~;~
denaturation and the preservation of mRNA during its extraction from cells I is not thought to have been recognized or exploited, prior to the present ¦ invention. The foregoing analysis, if correct, suggests that the preferred ¦ denaturant will be one having a low threshold denaturing concentration ¦ combined with a high aqueous solubility. For this reason, guanidinium thiocyanate is preferred over lithium diiodosalicylate even thou~h the ¦ letter is a more potent denaturant~ because the solubility of guanidinium I thiocyanate is much greater, hence it can be used at a concentration ¦I permitting more rapid RNase inactivation. The foregoing analysis also I explains why guanidinium thiocyanate is preferred over the comparably soluble hydrochloride salt, since the former is a somewhat more potent l denaturant , '.
The use of a disulfide bond breaking agent in combination with a ~ denaturant potentiates and enhances the effectiveness of the latter by 1I permitting the RNase molecule to become completely unfolded. The thiol compound is thought to enhance the forward rate of the denaturation process by preventing the rapid renaturation which can occur when the intramolecular disulfide bonds are left intact. Furthermore, any conta~inating RNase ~ remaining in the mRNA preparation will remain substantially inactive, even ~i in the absence of the denaturant and thiol. Disulfide bond breaking agents having thiol groups will be effective to some extent at any concentration, although generally speaking, a large excess of thiol groups to intra-molecular disulfide bonds is preferred to drive the interchange reaction ~` in the direction of intramolecular disulfide cleavage. On the other l hand, many thiol compounds are malodorous and unpleasant to work with j in high concentration, so that a practical upper concentration limit ¦ exists. Using ~-mercaptoethanol, concentrations in the range from .05M
to l.OM have been found effective, and 0.2M is considered optimal, for I¦ the isolation of undegraded in RNA from rat pancreas.
1I The pH of the medium during extraction of mRNA from cells may be l anywhere in the rang`e of pH 5.0 - 8Ø
l l l . .
I ~5-Example Islet cells of rat pancreas were prepared according to ~opending U S application 805,023, incorporated herein by reference.
~ ~ Islet cells pooled from 2~0 rats were homogenized in 4 M guanidinium thiocyanate containing ~ mercaptoethanol buffered to pH 5.0 at 4C.
The homogenate was layered over 1.2 ml, 5.7 M CsCl containing lOO mM EDTA
and centrifuged for 18 hours at 37,000 rpm in the SW 50.1 rotor of a Beckman Ultracentrifuge at 15C (Beckman Instrument Company, Fullerton, I California). RNA traveled to the bottom of the tube.
lll Polyadenylated RNA was isolated by chromatography of the total RNA
preparation on oligo(dT)-cellulose according to the procedure of Aviv, H., and Leder, P., supra.
Avian myeloblastosis virus reverse transcriptase, provided by D.J.
~i Beard, Life Science Inc., St. Petersburg, Florida, was used to transcribe i total polyadenylated RNA from rat islets of Langerhans into cDNA. The ,~ reactions were carried out in 50 mM Tris-HCl, pH 8.3 9 mM MgC12, 30 mM NaCl, 20 mM beta-mercaptoethanol, 1 m~I each of 3 nonradioactive deoxyribonucleoside triphosphates, 250JuM of the fourth deoxynucleoside triphosphate labeled with d<_32p, specific activity 50-200 curies per mole, 20~ug/ml oligo-dT12_1g 1i from Collaborative Research9 Waltham, Massachusetts, 100Jug/ml polyadenylatedRNA and 200 units/ml reverse transcriptase. The mi~ture was incubated at !~ 45C for fifteen minutes. After addition of EDTA-Na2 to 25 mM, the solution ,i was extracted with an equal volume of water-saturated phcnol, followed by I' chromatography of the aqueous phase on a Sephadex G-100 column, 0O3 cm in ~ diameter by 10 cm in height, in 10 mM Tris-HCl, pH 9.0, 100 mM NaC1, 2 mM
I EDTA. Nucleic acid eluted in the void volume was precipltated with ethanol ¦l after addition of ammonium acetate, pH 6.0, to 0.25M. The precipitate was collected by centrifugation, the pellet was dissolved in 50,ul of freshly '! prepared 0.1M NaOH and incubated at 70C for 20 minutes to hydrolyze the ii RNA. The mixture was neutralized by the addition of lM sodium acetate, pH
~ 1/ Tridom, trademark, Fluke AG Chemische Fabrik, Buchs, Switzerland.
~' .
¦1 4.5, and the 32P-cDNA product was precipitated with ethanol and redissolved in water. Aliquots of single stranged cDNA were analyzed on native polyacrylamide gels by the method of Dingman, C.~., and Peacock, A.C., 1 Biochemistry 7, ~59 (1968). The gels were dried and the 32p DNA detected 1 by autoradiography using Kodak No-Screen NS-2T ~ilm. The cDNA was 1 heterodisperse, as judged by the electrophoresis pattern. It contained at ! least one prominent cDNA species of about 450 nucleotides, as judged by ! I comparison with known standards.
I¦ The cDNA of about 450 nucleotides in length was cloned by transfer '', to and replication in a bacterial strain, reisolated and subjected to sequence analysis. It was found to comprise all but the first five nucleotides of the coding sequence for rat proinsulin I, as well as a portion of the 3'-untranslated region. Bearing in mind that length hetero-,' geneity is introduced during reverse transcription of the isolated mRNA
" template, it was concluded that the mRNA had been isolated substantially undegraded from the rat pancreas.
GENERAL CONCLUDING REMARKS
The ability to isolate undegraded mRNA according the present invention I represents a substantial improvement over prior art procedures. The mRN~
l~ has been isolated, as described herein, from a tissue well known to contain large amounts of RNase. The disclosed method and reagent composition used to inhibit RNase under these conditions is suitable for use in the `` isolation of RNA from other sources having comparable or lesser amounts ., , ~, of RNase, and is also considered suitable for RNA isolation from sources ., , i containing even greater amounts of RNase.
,1 While the invention has been described in connection with specific embodiments thereof, it will be understood that it is capable of further modifications and this application is intended to cover any variations, ,~ uses, or adaptations of the invention following, in general, the principles , of the invention and including such departures from the present disclosure :
chain cannot be tolerated~ when the mRNA is isolated for cloning purposes, ,, since that would destroy the sequence continuity necessary to preserve ,i the genetic lnformation.
The difficul~ie~ are especially acute in dealing ~ith extracts of l! pancreas cells 7 since the pancreas is a source of digesti~e enzymes and ¦¦ therefore, is rich in RNase. HGwever, the problem of RNase contamination i is present in all tissues. The method disclosed herein to eliminate R~ase activity is applicable to all tissues. The exceptional effectiveness of the method is demonstrated in the present invention by the successful isolation of intact mRNA from isolated islet cells of the pancreas.
Prior Art RNase is a name applied collectively to a group of similar en~ymes 0 1 found to some extent in virtually all biological materials. Pancreatic RNase is a fairly typical example, and its structure is ~uite ~ell known.
The enzyme i5 a relatively low molecular weight protein possessing inter-molecular disulfide bonds. Catalytic activity is depen~ent upon a certain . . , . ~
a54q12 folded configuration of the amino acid chain, termed the native con-figuration. Denaturation is the name given to any process which leads to unfolding or rearrangement of the amino acid chain such that the nati~e, catalytically active configuration is lost.
Denaturation of RNase is relatively diff~cult to achieve. The inter--molecular disulfide bonds maintain the amino acid chain in a configuration approximating the native configuration. If the disulfide bonds are left intact, renaturation occurs rapidly, upon removal o~ denaturant. Even I when the disulfide bonds are broken, the enzyme is capable of spontaneously I recovering the native configuration under appropriate conditions, although li, the process is much slower.
¦¦ The denaturation of RNase by the use of chaotropic ions has been il reported. For a general discussion of chaotropes and denaturation, see I¦ Jencks, W.P., Catalysis in Chemistry and Enzymology, Chapt. 7 (1969). In ~I particular, the denaturation of RNase by guanidinium thlocyanate, a salt having both a chaotropic anion and a chaotropic cation, has been demon- !
strated by VonHippel, P.H. and Wong, K-Y, Science 145, 577 (1964).
Numerous strategies have been employed in the prior art to isolate j undegraded RNA from biological sources. The success of such procedures jj has been defined relative to the nature and purpose of the RNA isolation ¦l and to the amount of degradation which could be tolerated. One strategy employed in the prior art is the use of an adsorbant, such as bentonite, to remove RNase from the cell extract. Another strategy has been the ' complete deproteinization of the cell e~tract. Phenol i9 commonly used ii for this purpose. Guanidinium hydrochloride has also been employed as a li deproteinizing agent for the preparation of nucleic acids, and its use has been reviewed by Cox, R.A., Methods in Enzymology (L. Grossman and K. Moldave, eds.) vol. 12B, 120 (196~). Although such procedures may ¦I be employed to isolate high molecular weight RNA, they are not adequate !i for the isolation of mRNA for cloning purposes, where even the hydrolysis of a single phosphodiester bond would render the entire molecule useless ~ 354U2 for the purpose of transferring an intact gel~etic sequence to a micro-organism. The difficulties are exacerbated when the isolation is attempted from a tissue high in RNase content, such as pancreas. Rat pancreas contains as much as 200JUg of RNase per gram of tissue and even higher amounts are found to occur in other mammalian pancreases.
SUMMARY OF THE INVENTION
RNase is effectively inhibited during isolation ~rom intact cells by homogenizing a cell preparation in guanidinium thiocyanate buffered to low 1~ pH and containing mercaptoethanol. In combination with the denaturing , action of guanidinium thiocyanate, mercaptoethanol further reduces RNase Il acti~ity by disrupting its intermolecular disulfide bonds. The combination i of mercaptoethanol with a potent denaturing agent such as guanidinium 1, j thiocyanate, pursuant to this invention, tends to enhance the effectiveness Il of mercaptoethanol by rendering the inactivation of RNase essentially ,` irreversible. The pH may be varied in the range Df 5.0 - 8Ø
., , " DETAILED DESCRI~TION OF THE INVENTION -The present invention employs in combination a chaotropic anion, a chaotropic cation and a disulfide bond-breaking agent, during cell I disruption and during all operations required to separate RNA essentially ~I free from protein. The effectiveness of the combined action of the fore-going agents has been demonstrated by their use in the isolation of essentially undegraded mRNA in good yield from isolated islets of Langerhans of rat pancreas.
jl Choice of suitable chaotropic ions is based upon their solubility in li aqueous media and upon availability. Suitable chaotropic cations include li guanidinium, carbamoylguanidinium, guanylguanidinium, lithium and the like.
¦l Suitable chaotropic anions include iodide, perchlorate, thiocyanate, j diiodosalicylate and the like. The relatiYe effectiveness of salts formed 1l by combining such cations and anions will be determined in par~ by their l i , I ~, I! .
solubility. For example, lithium diiodosalicylate is a more potent denaturan~---than guanidinium thiocyanate, but it has a solubility of only about 0.lM and is also relatively expen-sive. Guanidinium thiocyanate provides the preferred cation-anion con~ination, because it is readily available and is highly soluble in aqueous media, up to about 5M.
Thiol compounds, such as ~-mercaptoethanol, are ~nown to break intramolecular disulfide bonds in proteins by a thiol-disulfide interchange reaction. Many suitable thiol compounds are known to be effective, including besides ~-mercaptoethanol, dithiothreitol, cysteine, propanol di-mercaptan and the like. Aqueous solubility is a necessary property, since the thiol compound must be present in large excess over the intramolecular disulfides, in order to drive the interchange reaction essentially to completion. ~-mercapto-ethanol is preferred because of its ready availability at reasonable price.
For the purpose of inhibiting RNase during extrac-tion of RNA from cells or tissues, the effectiveness of a given chaotropic salt is directly related to its concentra-tion. The preferred concentration is therefore the highest concentration that can be employed, as a practical matter.
The success of the present invention in preserving mRNA intact during extraction is thought to depend upon the rapidity with which the RNase is denatured, in addition to the extent of denaturation. This is thought to explain, for example, the superio~ity of guanidinium thiocyanate over the hydrochloride, despite the fact that the hydrochloride is only slightly less potent as a denaturing agent. The efectiveness of a denaturant is defined as the threshold concentration needed to achieve complete denaturation o a protein. On the other hand, the rate of denaturation of many proteins is ~ ~5~
dependent on the denaturant concentration, relative to the threshold, raised to from -the 5th to the 10th power. See Tanford, C.A., Ad~. Prot. Chem. 23, 121 (1968). Qualitatively this relationship suggests that a denaturant only slightly more potent than guanidinium hydrochloride can denature a protein many times more rapidly a~ the same concentration.
The relationship between the kinetics of RNase , 54~;~
denaturation and the preservation of mRNA during its extraction from cells I is not thought to have been recognized or exploited, prior to the present ¦ invention. The foregoing analysis, if correct, suggests that the preferred ¦ denaturant will be one having a low threshold denaturing concentration ¦ combined with a high aqueous solubility. For this reason, guanidinium thiocyanate is preferred over lithium diiodosalicylate even thou~h the ¦ letter is a more potent denaturant~ because the solubility of guanidinium I thiocyanate is much greater, hence it can be used at a concentration ¦I permitting more rapid RNase inactivation. The foregoing analysis also I explains why guanidinium thiocyanate is preferred over the comparably soluble hydrochloride salt, since the former is a somewhat more potent l denaturant , '.
The use of a disulfide bond breaking agent in combination with a ~ denaturant potentiates and enhances the effectiveness of the latter by 1I permitting the RNase molecule to become completely unfolded. The thiol compound is thought to enhance the forward rate of the denaturation process by preventing the rapid renaturation which can occur when the intramolecular disulfide bonds are left intact. Furthermore, any conta~inating RNase ~ remaining in the mRNA preparation will remain substantially inactive, even ~i in the absence of the denaturant and thiol. Disulfide bond breaking agents having thiol groups will be effective to some extent at any concentration, although generally speaking, a large excess of thiol groups to intra-molecular disulfide bonds is preferred to drive the interchange reaction ~` in the direction of intramolecular disulfide cleavage. On the other l hand, many thiol compounds are malodorous and unpleasant to work with j in high concentration, so that a practical upper concentration limit ¦ exists. Using ~-mercaptoethanol, concentrations in the range from .05M
to l.OM have been found effective, and 0.2M is considered optimal, for I¦ the isolation of undegraded in RNA from rat pancreas.
1I The pH of the medium during extraction of mRNA from cells may be l anywhere in the rang`e of pH 5.0 - 8Ø
l l l . .
I ~5-Example Islet cells of rat pancreas were prepared according to ~opending U S application 805,023, incorporated herein by reference.
~ ~ Islet cells pooled from 2~0 rats were homogenized in 4 M guanidinium thiocyanate containing ~ mercaptoethanol buffered to pH 5.0 at 4C.
The homogenate was layered over 1.2 ml, 5.7 M CsCl containing lOO mM EDTA
and centrifuged for 18 hours at 37,000 rpm in the SW 50.1 rotor of a Beckman Ultracentrifuge at 15C (Beckman Instrument Company, Fullerton, I California). RNA traveled to the bottom of the tube.
lll Polyadenylated RNA was isolated by chromatography of the total RNA
preparation on oligo(dT)-cellulose according to the procedure of Aviv, H., and Leder, P., supra.
Avian myeloblastosis virus reverse transcriptase, provided by D.J.
~i Beard, Life Science Inc., St. Petersburg, Florida, was used to transcribe i total polyadenylated RNA from rat islets of Langerhans into cDNA. The ,~ reactions were carried out in 50 mM Tris-HCl, pH 8.3 9 mM MgC12, 30 mM NaCl, 20 mM beta-mercaptoethanol, 1 m~I each of 3 nonradioactive deoxyribonucleoside triphosphates, 250JuM of the fourth deoxynucleoside triphosphate labeled with d<_32p, specific activity 50-200 curies per mole, 20~ug/ml oligo-dT12_1g 1i from Collaborative Research9 Waltham, Massachusetts, 100Jug/ml polyadenylatedRNA and 200 units/ml reverse transcriptase. The mi~ture was incubated at !~ 45C for fifteen minutes. After addition of EDTA-Na2 to 25 mM, the solution ,i was extracted with an equal volume of water-saturated phcnol, followed by I' chromatography of the aqueous phase on a Sephadex G-100 column, 0O3 cm in ~ diameter by 10 cm in height, in 10 mM Tris-HCl, pH 9.0, 100 mM NaC1, 2 mM
I EDTA. Nucleic acid eluted in the void volume was precipltated with ethanol ¦l after addition of ammonium acetate, pH 6.0, to 0.25M. The precipitate was collected by centrifugation, the pellet was dissolved in 50,ul of freshly '! prepared 0.1M NaOH and incubated at 70C for 20 minutes to hydrolyze the ii RNA. The mixture was neutralized by the addition of lM sodium acetate, pH
~ 1/ Tridom, trademark, Fluke AG Chemische Fabrik, Buchs, Switzerland.
~' .
¦1 4.5, and the 32P-cDNA product was precipitated with ethanol and redissolved in water. Aliquots of single stranged cDNA were analyzed on native polyacrylamide gels by the method of Dingman, C.~., and Peacock, A.C., 1 Biochemistry 7, ~59 (1968). The gels were dried and the 32p DNA detected 1 by autoradiography using Kodak No-Screen NS-2T ~ilm. The cDNA was 1 heterodisperse, as judged by the electrophoresis pattern. It contained at ! least one prominent cDNA species of about 450 nucleotides, as judged by ! I comparison with known standards.
I¦ The cDNA of about 450 nucleotides in length was cloned by transfer '', to and replication in a bacterial strain, reisolated and subjected to sequence analysis. It was found to comprise all but the first five nucleotides of the coding sequence for rat proinsulin I, as well as a portion of the 3'-untranslated region. Bearing in mind that length hetero-,' geneity is introduced during reverse transcription of the isolated mRNA
" template, it was concluded that the mRNA had been isolated substantially undegraded from the rat pancreas.
GENERAL CONCLUDING REMARKS
The ability to isolate undegraded mRNA according the present invention I represents a substantial improvement over prior art procedures. The mRN~
l~ has been isolated, as described herein, from a tissue well known to contain large amounts of RNase. The disclosed method and reagent composition used to inhibit RNase under these conditions is suitable for use in the `` isolation of RNA from other sources having comparable or lesser amounts ., , ~, of RNase, and is also considered suitable for RNA isolation from sources ., , i containing even greater amounts of RNase.
,1 While the invention has been described in connection with specific embodiments thereof, it will be understood that it is capable of further modifications and this application is intended to cover any variations, ,~ uses, or adaptations of the invention following, in general, the principles , of the invention and including such departures from the present disclosure :
2/ Trademark, Eastman Kodak Corporation, Rochester, New York.
_7_ .. . .
~54~2 I as come within known or customary practice within the art to which the ¦ invention pertains or which would be readily apparent to those skilled ¦l in said art. With that ~mderstanding, the invention is not to be limited except to t~e e~tent required by the appended tlaims.
_7_ .. . .
~54~2 I as come within known or customary practice within the art to which the ¦ invention pertains or which would be readily apparent to those skilled ¦l in said art. With that ~mderstanding, the invention is not to be limited except to t~e e~tent required by the appended tlaims.
Claims (8)
1. A method of preparing a cell extract essentially free of RNase activity, comprising:
homogenizing a population of cells at controlled pH in the combined presence of a protein denaturing agent and a disulfide bond breaking agent.
homogenizing a population of cells at controlled pH in the combined presence of a protein denaturing agent and a disulfide bond breaking agent.
2. The method of claim 1 wherein the protein denaturing agent is guanidinium thiocyanate and the disulfide bond breaking agent is mercap-toethanol.
3. An RNase inhibitor composition comprising a chaotropic cation, a chaotropic anion and a disulfide bond breaking agent.
4. A composition according to claim 3 wherein the chaotrepic cation is guanidinium and the chaotropic anion is thiocyanate.
5. A composition according to claim 3 wherein the disulfide bond disrupting agent is .beta.-mercaptoethanol.
6. A composition according to claim 3 comprising 4 M guanidinium thiocyanate and 0.2 M .beta.-mercaptoethanol.
7. A method of isolating substantially undegraded RNA from cells comprising:
extracting RNA from the cells in the combined presence of a protein denaturing agent and a disulfide bond breaking agent, and fractionating the cell extract to separate RNA from protein, whereby substantially undegraded RNA is isolated.
extracting RNA from the cells in the combined presence of a protein denaturing agent and a disulfide bond breaking agent, and fractionating the cell extract to separate RNA from protein, whereby substantially undegraded RNA is isolated.
8. The method of claim 7 wherein the protein denaturing agent is guanidinium thiocyanate and the disulfide bond breaking agent is .beta.-mercaptoethanol.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80134377A | 1977-05-27 | 1977-05-27 | |
US801,343 | 1977-05-27 | ||
US80502377A | 1977-06-09 | 1977-06-09 | |
US805,023 | 1977-06-09 | ||
US89900278A | 1978-04-26 | 1978-04-26 | |
US899,002 | 1978-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1105402A true CA1105402A (en) | 1981-07-21 |
Family
ID=27419972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA303,930A Expired CA1105402A (en) | 1977-05-27 | 1978-05-24 | Isolation of undegraded rna |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA1105402A (en) |
-
1978
- 1978-05-24 CA CA303,930A patent/CA1105402A/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ziegler et al. | [14] Hepatic microsomal mixed-function amine oxidase | |
Danielsen et al. | A neutral endopeptidase in the microvillar membrane of pig intestine. Partial purification and properties | |
Williams et al. | Purification and characterization of pyruvate: ferredoxin oxidoreductase from the anaerobic protozoon Trichomonas vaginalis | |
Mozhaev et al. | Inactivation and reactivation of proteins (enzymes) | |
Takamori et al. | Skin sulfhydryl oxidase purification and some properties | |
Ostrowski et al. | A flavoprotein responsible for the intense sulfhydryl oxidase activity of rat seminal vesicle secretion | |
Kerr et al. | Soybean leaf urease: comparison with seed urease | |
Heinz et al. | [52] Glyceraldehyde-3-phosphate dehydrogenase from human tissues | |
Stone et al. | Purification and partial amino acid sequence of a high‐activity human stomach alcohol dehydrogenase | |
Postlind et al. | Cloning, Structure, and Expression of a cDNA Encoding Vitamin D325-Hydroxylase | |
Fessenden-Raden | Purification and properties of a new coupling factor required for oxidative phosphorylation in silicotungstate-treated submitochondrial particles | |
Mukherjee et al. | Purification, properties, and N-terminal amino acid sequence of homogeneous Escherichia coli 2-amino-3-ketobutyrate CoA ligase, a pyridoxal phosphate-dependent enzyme. | |
Bellion et al. | An NAD+-dependent alanine dehydrogenase from a methylotrophic bacterium | |
Morin et al. | Characterization, kinetics and comparative properties of thiol: protein disulfide oxidoreductase | |
Dailey et al. | [47] Purification and characterization of mammalian and chicken ferrochelatase | |
CA1105402A (en) | Isolation of undegraded rna | |
Tanis et al. | Purification and properties of carbonic anhydrase from sheep erythrocytes | |
Bitar et al. | Histidinol dehydrogenase from Salmonella typhimurium and Escherichia coli: Purification, some characteristics and the amino acid sequence around a reactive thiol group | |
Blonde et al. | THE EFFECTS OF IONS AND FREEZE–THAWING ON SUPERNATANT AND MITOCHONDRIAL MALATE DEHYDROGENASE | |
Hemler et al. | Protection of cyclooxygenase activity during heme-induced destabilization | |
Schalk et al. | Rapid purification of the Aeromonas proteolytica aminopeptidase: crystallization and preliminary X-ray data | |
Lomri et al. | Expression in Escherichia coli of the cloned flavin-containing monooxygenase from pig liver. | |
JP4076812B2 (en) | Nucleic acid degradation prevention method, nucleic acid extraction method, and nucleic acid storage method | |
Nagai et al. | Histidinol dehydrogenase loses its catalytic function through the mutation of His261→ Asn due to its inability to ligate the essential Zn | |
Hunter et al. | The role of cytochrome c 4 in bacterial respiration. Cellular location and selective removal from membranes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |